Literature DB >> 4632770

Clinical evaluation of Pseudomonas hyperimmune globulin.

C E Jones, J W Alexander, M Fisher.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4632770     DOI: 10.1016/0022-4804(73)90014-0

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


× No keyword cloud information.
  9 in total

Review 1.  Antibiotic agents and the immune mechanisms of defense.

Authors:  J W Alexander
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Cooperative group of additional immunoglobulin therapy in severe bacterial infections: multicenter randomized controlled trial on the efficacy of additional immunoglobulin therapy in cases of diffuse fibrino-peritonitis - study design.

Authors: 
Journal:  Klin Wochenschr       Date:  1983-05-02

3.  [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].

Authors:  J E Pennington; G B Pier
Journal:  Infection       Date:  1987       Impact factor: 3.553

4.  Protection of immunosuppressed mice against infection with pseudomonas aeruginosa by monoclonal antibodies to outer membrane protein OprI.

Authors:  R Rahner; A Eckhardt; M Duchêne; H Domdey; B U von Specht
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

5.  Depression of the antibody response in Pseudomonas aeruginosa-injected mice.

Authors:  C Garzelli; V Colizzi; M Campa; L Bozzi; G Falcone
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

6.  [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].

Authors:  J E Pennington; G B Pier
Journal:  Infection       Date:  1987 Jan-Feb       Impact factor: 3.553

7.  Passive immunity against pseudomonas sepsis during granulocytopenia.

Authors:  L Harvath; B R Andersen; H J Amirault
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

8.  Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

9.  Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.609

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.